Published: 24 March 2024
Author(s): Penghui Yang, Jing Zhang, Siqi Feng, Qijian Yi
Issue: May 2024
Section: Letter to the Editor

Kawasaki disease (KD) can result in coronary artery aneurysms (CAA), elevating the risk of coronary artery thrombosis in the later stage [1]. Intravenous immunoglobulin within the first 10 days after fever onset is the primary therapy for KD, which greatly reduces the incidence of CAA [1].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.